| Image Source: https://www.centerforhealthsecurity.org/ |
The meeting explored next steps and priorities for the incoming administration to improve the US bioeconomy for the future. Sessions featured how biotech companies have pivoted during COVID-19 to address medical needs; imagining what the post-COVID 19 bioeconomy should look like with regards to non-medical applications, regulations, and investments; addressing climate change; and developing the future biotech workforce.
This session evaluated the role misinformation has played in health emergencies and offered solutions to increase trust in future public health messaging.
This session will explore the current state, successes, and remaining challenges of global vaccine development, manufacturing, distribution, and delivery. It will highlight actionable steps the U.S. Government can take to bring an end to the acute crisis of this pandemic and meet the scale of future infectious disease threats.
